(Q43882763)

27 November 2017

Point mutations of the BCL-6 gene: clinical and prognostic correlation in B-diffuse large cell lymphoma (English)

1 reference

27 November 2017

0 references

Vitolo U

1

1 reference

27 November 2017

Botto B

2

1 reference

27 November 2017

Capello D

3

1 reference

27 November 2017

Vivenza D

4

1 reference

27 November 2017

Zagonel V

5

1 reference

27 November 2017

Gloghini A

6

1 reference

27 November 2017

Novero D

7

1 reference

27 November 2017

Parvis G

8

1 reference

27 November 2017

Calvi R

9

1 reference

27 November 2017

Ariatti C

10

1 reference

27 November 2017

Milan I

11

1 reference

27 November 2017

Bertini M

12

1 reference

27 November 2017

Boccomini C

13

1 reference

27 November 2017

Freilone R

14

1 reference

27 November 2017

Pregno P

15

1 reference

27 November 2017

Orsucci L

16

1 reference

27 November 2017

Palestro G

17

1 reference

27 November 2017

Saglio G

18

1 reference

27 November 2017

Carbone A

19

1 reference

27 November 2017

Gallo E

20

1 reference

27 November 2017

Gaidano G

21

1 reference

27 November 2017

1 February 2002

1 reference

27 November 2017

1 reference

27 November 2017

16

1 reference

27 November 2017

2

1 reference

27 November 2017

268-275

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402349

27 November 2017

0 references

cites work

Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402349

7 January 2021

LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402349

7 January 2021

Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402349

7 January 2021

Molecular heterogeneity of B-lineage diffuse large cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402349

7 January 2021

Pathogenetic and clinical implications of Bcl-6 and Bcl-2 gene configuration in nodal diffuse large B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402349

7 January 2021

Frequent somatic hypermutation of the 5' noncoding region of the BCL6 gene in B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402349

7 January 2021

Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402349

7 January 2021

BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402349

7 January 2021

MUM1: a step ahead toward the understanding of lymphoma histogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402349

7 January 2021

Intensified and high-dose chemotherapy with granulocyte colony-stimulating factor and autologous stem-cell transplantation support as first-line therapy in high-risk diffuse large-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402349

7 January 2021

High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell Lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402349

7 January 2021

Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402349

7 January 2021

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402349

7 January 2021

Clinical significance of bcl-2-MBR gene rearrangement and protein expression in diffuse large-cell non-Hodgkin's lymphoma: an analysis of 83 cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402349

7 January 2021

Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: Clinical relevance in 71 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402349

7 January 2021

Frequent disruption of the RB1 pathway in diffuse large B cell lymphoma: prognostic significance of E2F-1 and p16INK4A.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402349

7 January 2021

Characterization of a novel HHV-8-positive cell line reveals implications for the pathogenesis and cell cycle control of primary effusion lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402349

7 January 2021

Combined modality treatment with a weekly brief chemotherapy (ACOP-B) followed by locoregional radiotherapy in localized-stage intermediate- to high-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402349

7 January 2021

MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402349

7 January 2021

MACOP-B and VACOP-B in diffuse large cell lymphomas and MOPP/ABV in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402349

7 January 2021

P-VEBEC: a new 8-weekly schedule with or without rG-CSF for elderly patients with aggressive non-Hodgkin's lymphoma (NHL)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402349

7 January 2021

A combination of mitoxantrone, etoposide and prednisone in elderly patients with non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402349

7 January 2021

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402349

7 January 2021

Molecular profile of Epstein-Barr virus infection in HHV-8-positive primary effusion lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402349

7 January 2021

Identification of three subgroups of B cell chronic lymphocytic leukemia based upon mutations of BCL-6 and IgV genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402349

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402349

7 January 2021

VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402349

7 January 2021

Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402349

7 January 2021

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402349

7 January 2021

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402349

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2402349

1 reference

Dimensions Publication ID

27 November 2017

0 references

1 reference